Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous MSC Coated Fistula Plug in Pediatric Crohn's Disease
NCT03014219Phase 1Withdrawn
- Start
- Jul 2017
- Primary completion
- Jul 2019
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of autologous mesenchymal stromal cells in perianal fistula and Crohn's disease. Primary endpoint: Number of Subjects with any Adverse Events that are related to study drug at 24 months. Planned start Jul 2017; status: withdrawn.
02
Drugs
autologous mesenchymal stromal cells
03
Conditions
perianal fistulaCrohn's disease
Beyond the preview
Go deeper on NCT03014219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03014219.